solirisnmosd-hcp.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
User-agent: * Disallow: | ||
Meta Tags
| Title | SOLIRIS® (eculizumab) Home | HCP |
| Description | Empower your adult SOLIRIS® (eculizumab) is used to treat patients with NMOSD. Please see Important Safety Information, including Boxed Warning, and Medication |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 13.32.43.16 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
solirisnmosd-hcp.com Valuation
|
US$5,376,165
Last updated: 2023-05-16 20:01:40
solirisnmosd-hcp.com has Semrush global rank of 1,968,746. solirisnmosd-hcp.com has an estimated worth of US$ 5,376,165, based on its estimated Ads revenue. solirisnmosd-hcp.com receives approximately 620,327 unique visitors each day. Its web server is located in United States, with IP address 13.32.43.16. According to SiteAdvisor, solirisnmosd-hcp.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$5,376,165 |
| Daily Ads Revenue | US$4,963 |
| Monthly Ads Revenue | US$148,879 |
| Yearly Ads Revenue | US$1,786,541 |
| Daily Unique Visitors | 41,356 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| solirisnmosd-hcp.com. | A | 59 | IP: 13.32.43.16 |
| solirisnmosd-hcp.com. | A | 59 | IP: 13.32.43.116 |
| solirisnmosd-hcp.com. | A | 59 | IP: 13.32.43.119 |
| solirisnmosd-hcp.com. | A | 59 | IP: 13.32.43.2 |
| solirisnmosd-hcp.com. | NS | 86400 | NS Record: ns-1196.awsdns-21.org. |
| solirisnmosd-hcp.com. | NS | 86400 | NS Record: ns-166.awsdns-20.com. |
| solirisnmosd-hcp.com. | NS | 86400 | NS Record: ns-1995.awsdns-57.co.uk. |
| solirisnmosd-hcp.com. | NS | 86400 | NS Record: ns-678.awsdns-20.net. |
| solirisnmosd-hcp.com. | TXT | 300 | TXT Record: google-site-verification=cVttuTyJxHbkYVQ3WunBRDKBN17yOjGZqdIIYfDGKYI |
HtmlToTextCheckTime:2023-05-16 20:01:40
| Important Safety Information SOLIRIS REMS Prescribing Information Important Safety Information SOLIRIS REMS Prescribing Information SOLIRIS Indications For Patients Home Risk of Relapse About SOLIRIS Study Design Efficacy Safety Mechanism of Action Prescribing SOLIRIS SOLIRIS REMS Vaccinations Dosing Support & Resources Resources OneSource™ Support Find an Infusion Center STAY CONNECTED STAY CONNECTED SOLIRIS ® (eculizumab) is the first FDA-approved complement inhibitor indicated for the treatment of adults with anti-aquaporin-4 (AQP4) antibody-positive neuromyelitis optica spectrum disorder (NMOSD). 1 Empower your adult patients with anti-AQP4 antibody-positive NMOSD In the PREVENT clinical trial, SOLIRIS was found to be superior to placebo based on time to first adjudicated on-trial relapse (primary endpoint). 1 in the risk of relapse in adult patients treated with SOLIRIS compared to placebo (Hazard ratio=0.058; P <0.0001). 1 98% of patients who were treated with SOLIRIS were |
HTTP Headers
HTTP/1.1 301 Moved Permanently Server: CloudFront Date: Thu, 10 Feb 2022 10:09:31 GMT Content-Type: text/html Content-Length: 183 Connection: keep-alive Location: https://solirisnmosd-hcp.com/ X-Cache: Redirect from cloudfront Via: 1.1 228e9f9ffd3a938a52da99b2c67d587e.cloudfront.net (CloudFront) X-Amz-Cf-Pop: HEL50-C1 X-Amz-Cf-Id: I9gNgq5NWKYoJYqzVtCEiqInSJMkkVwl7GzOJzbQsjHBpynhPwLowg== HTTP/2 200 content-type: text/html; charset=utf-8 content-length: 63189 vary: Accept-Encoding cache-control: no-cache, no-store cd: SC9-01 date: Thu, 10 Feb 2022 10:09:31 GMT expires: -1 pragma: no-cache server: Microsoft-IIS/10.0 set-cookie: ASP.NET_SessionId=az1fecgalzrq1n05kqvbijld; path=/; HttpOnly; SameSite=Lax set-cookie: ASP.NET_SessionId=az1fecgalzrq1n05kqvbijld; path=/; HttpOnly; SameSite=Lax set-cookie: __RequestVerificationToken=_tsJNBb0h2iXZjjnjr7CTyD-f0WXqxnYdnPfCE4xrsV2SdafGQWTLNyNt5P-yRkN7WuqeJBG0FIOSsu7o66mxWUyhhD7MMtVIc3BqxgYcIc1; path=/; HttpOnly x-frame-options: SAMEORIGIN x-cache: Miss from cloudfront via: 1.1 16680cb8308307715d75bb3354b1ae38.cloudfront.net (CloudFront) x-amz-cf-pop: HEL50-C1 x-amz-cf-id: nPf48lZufoGIbIZx7hVynHQkHMvvONpkzl_pEUVNDmexDSrbJqqj5Q== |
solirisnmosd-hcp.com Whois Information
Domain Name: SOLIRISNMOSD-HCP.COM Registry Domain ID: 2368887542_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.markmonitor.com Registrar URL: http://www.markmonitor.com Updated Date: 2022-02-09T09:19:57Z Creation Date: 2019-03-13T15:21:58Z Registry Expiry Date: 2023-03-13T15:21:58Z Registrar: MarkMonitor Inc. Registrar IANA ID: 292 Registrar Abuse Contact Email: abusecomplaints@markmonitor.com Registrar Abuse Contact Phone: +1.2083895740 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS-1196.AWSDNS-21.ORG Name Server: NS-166.AWSDNS-20.COM Name Server: NS-1995.AWSDNS-57.CO.UK Name Server: NS-678.AWSDNS-20.NET DNSSEC: unsigned >>> Last update of whois database: 2022-02-10T07:29:43Z <<< |